Evidence map›Paper›PMID 39366921›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2024

Successful Use of Dupilumab in Atopic Dermatitis-Like Graft-Versus-Host Disease: A Case Report.

Qingjun Liao, Catherine Y Lee, Yunfeng Hu, Shi Wu, Yong He

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qingjun LiaoDepartment of Dermatology, The First Affiliated Hospital of Jinan University, Guangzhou, China.ORCID https://orcid.org/0009-0003-7691-9670
Catherine Y LeeDepartment of Dermatology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Yunfeng HuDepartment of Dermatology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Shi WuDepartment of Dermatology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Yong HeDepartment of Dermatology, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Funding

Fundamental Research Funds for the Central Universities 21623321Science and Technology Projects in Guangzhou 2024A04J3938
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, Monoclonal, HumanizedDermatitis, AtopicGraft vs Host DiseaseHumansAntibodies, Monoclonal, Humanizeddupilumab

Identifiers

PMID39366921
PMCPMC11452251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.